Thank you!

Article

Although we have always received a steady stream of feedback from readers, contributors and industry, never have we been bombarded by so many compliments in such a short space of time as at two recent conferences.

I know this may sound a little dramatic (that's me I'm afraid), but I was close to tears on several occasions during two of the most recent congresses that I attended - the Euretina meeting in Vienna and the European Glaucoma Society congress in Berlin. My tears were those of joy. During these two meetings I was approached by so many of our readers, each offering kind words of support for the magazine and even congratulations. On one occasion, a well-respected European glaucoma surgeon, who I hold in very high esteem, praised the efforts of the OTE team so much that I had to restrain myself from hugging him! I also received a lovely gift from one of our readers and past contributors; a lovely bracelet, which was offered as thanks for accepting her research for publication.

Although we have always received a steady stream of feedback from readers, contributors and industry, both in writing and in person, never have we been bombarded by so many compliments in such a short space of time. I was elated.

Our team works very hard to deliver a service to you that we hope you find both useful and informative. By incorporating the views and experiences of ophthalmologists from all walks of life, it has been our aim to provide a forum for everyone.

Okay, that's the emotional stuff over with. On another note, the draw for the winner of the trip for two to Berlin took place in July and I would like to offer my personal congratulations to Dr André Muller who will be taking his wife on the luxury trip to Berlin in September. My sincere thanks to all of you who entered the competition. We will continue to run reader competitions so please do keep a look out for these at congresses, within our magazine and on our website in future.

With heartfelt thanks and best wishes,

Fedra PavlouEditorfpavlou@advanstar.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.